BSX
Boston Scientific Corp
44.70$
+0.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 38.6% | 37.9% | 38.2% | 37.3% | 37.1% | 41.4% | 36.7% | 32.3% | 30.1% | 25.5% | 30.6% | 29.3% | 28.8% | |
| 61.4% | 62.1% | 61.8% | 62.7% | 62.9% | 58.6% | 63.3% | 67.7% | 69.9% | 74.5% | 69.4% | 70.7% | 71.2% | |
| 10.1% | 9.7% | 9.5% | 9.3% | 9.7% | 10.1% | 9.5% | 10.4% | 10.1% | 10.8% | 9.9% | 10.2% | 10.3% | |
| 35.2% | 37.0% | 35.4% | 35.1% | 37.1% | 35.3% | 34.2% | 33.9% | 34.4% | 34.7% | 34.2% | 33.1% | 34.1% | |
| 45.6% | 47.1% | 45.1% | 44.6% | 46.9% | 45.6% | 44.0% | 51.5% | 49.2% | 51.7% | 48.8% | 49.1% | 49.7% | |
| 15.8% | 15.0% | 16.7% | 18.1% | 16.0% | 12.9% | 19.2% | 16.2% | 20.7% | 22.8% | 20.6% | 21.6% | 21.5% | |
| 1.9% | 1.8% | 1.9% | 2.0% | 2.0% | 3.0% | 1.9% | 1.8% | 1.7% | 1.7% | 1.7% | 1.8% | 1.7% | |
| 17.3% | 13.6% | 15.8% | 10.2% | 15.9% | 12.8% | 17.3% | 18.6% | 18.5% | 13.2% | 22.3% | 19.5% | 18.4% | |
| 3.0% | 0.0% | 3.0% | 2.4% | 4.8% | 0.5% | 2.9% | 2.9% | 3.6% | 0.6% | -3.4% | 2.8% | 0.9% | |
| 14.3% | 13.5% | 12.8% | 7.9% | 11.1% | 12.4% | 14.5% | 15.7% | 14.9% | 12.6% | 25.7% | 16.7% | 17.5% | |
| 27.7% | 23.8% | 25.5% | 19.7% | 25.1% | 23.5% | 26.1% | 27.0% | 27.0% | 21.9% | 30.8% | 25.5% | 26.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.